Our previous study showed that overexpression of Nrf2 due to Keap1 mutation increased cell invasion and metastatic ability of EGFR tyrosine kinase inhibitor (TKI)-resistant lung cancer cells both in vitro and in vivo. This evidence concerns the gene NFE2L2 and lung carcinoma.